Search Results 1161-1170 of 17635 for treatment resistant depression
The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell malignancies ...
The purpose of the ALLO-605-201 study is to assess the safety, effectiveness, and cell kinetics of ALLO605 in adults with relapsed or refractory multiple ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL. Rochester, Minn. This is a Phase 2 global, multi-center, open-label study to ...
Avant, M.D.. Palliative Care Specialist. Phoenix, AZ. Areas of focus: Palliative care, Depression ... resistant prostate cancer, Mycosis fungoides. Show ...
This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...
Treatment-resistant depression · Tricyclic antidepressants and tetracyclic antidepressants · Understanding the difference between dementia types · Vitamin B-12 ...
Allen, M.D.. Psychiatrist. Rochester, MN. Areas of focus: Electroconvulsive therapy, Substance abuse, Depression, Personality disorder, Bipolar disorder, Drug ...
... Resistant to Treatment Scottsdale/Phoenix, AZ; Rochester, MN. The purpose of ... treatment (refractory). Monoclonal antibodies, such as rituximab, may ...
Meropenem injection is used to treat infections caused by bacteria. It works by killing the bacteria or preventing their growth. This medicine will not work for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!